scPharmaceuticals Inc. (SCPH)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch SCPH
See up to 3 months of SCPH. The 7-day demo opens the 1M and 3M ranges and puts SCPH on your watchlist.
Start 7-day demoLatest SCPH insider trades
William Tober AbrahamDerivative30,000 sh- William Tober AbrahamDerivative19,750 sh
- William Tober AbrahamDerivative
About scPharmaceuticals Inc. (SCPH)
scPharmaceuticals Inc. is an SEC registrant, filing under CIK 0001604950, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
SCPH Form 4 activity by transaction type, last 90 days
No Form 4 activity for SCPH in the last 90 days.
SCPH insider transactions (Form 4)
4512 Form 4 filings on record, the earliest from Jun 3, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| William Tober Abraham | Derivative | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| William Tober Abraham | Derivative | Stock Option (Right to Buy) | 19,750 | $0.00 | - | |
| William Tober Abraham | Derivative | Stock Option (Right to Buy) | 16,300 | $0.00 | - | |
| Minnie Baylor-Henry | Derivative | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Minnie Baylor-Henry | Derivative | Stock Option (Right to Buy) | 19,750 | $0.00 | - | |
| Minnie Baylor-Henry | Derivative | Stock Option (Right to Buy) | 16,300 | $0.00 | - | |
| Minnie Baylor-Henry | Derivative | Stock Option (Right to Buy) | 6,124 | $0.00 | - | |
| Minnie Baylor-Henry | Derivative | Stock Option (Right to Buy) | 12,248 | $0.00 | - | |
 Rachael Nokes - Officer | Other | Common Stock | 30,386 | - footnote F1,F2 | - | |
| Rachael Nokes - Officer | Derivative | Common Stock | 125,675 | - footnote F3 | - | |
| Rachael Nokes - Officer | Derivative | Stock Option (Right to Buy) | 54,700 | $0.00 | - | |
| Rachael Nokes - Officer | Derivative | Stock Option (Right to Buy) | 132,670 | $0.00 | - | |
| Rachael Nokes - Officer | Derivative | Stock Option (Right to Buy) | 6,426 | $0.00 | - | |
| Rachael Nokes - Officer | Derivative | Stock Option (Right to Buy) | 13,850 | $0.00 | - | |
| ||||||
 Mette Kirstine Agger | Derivative | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Mette Kirstine Agger | Derivative | Stock Option (Right to Buy) | 19,750 | $0.00 | - | |
| Sara Bonstein | Derivative | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Sara Bonstein | Derivative | Stock Option (Right to Buy) | 19,750 | $0.00 | - | |
| Sara Bonstein | Derivative | Stock Option (Right to Buy) | 16,300 | $0.00 | - | |
| Jack A. Khattar | Other | Common Stock | 5,000 | - footnote F1,F2 | - | |
| Jack A. Khattar | Derivative | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Jack A. Khattar | Derivative | Stock Option (Right to Buy) | 19,750 | $0.00 | - | |
| Jack A. Khattar | Derivative | Stock Option (Right to Buy) | 16,300 | $0.00 | - | |
| Jack A. Khattar | Derivative | Stock Option (Right to Buy) | 6,124 | $0.00 | - | |
| ||||||
 Frederick M. Hudson | Derivative | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Frederick M. Hudson | Derivative | Stock Option (Right to Buy) | 19,750 | $0.00 | - | |
| Frederick M. Hudson | Derivative | Stock Option (Right to Buy) | 16,300 | $0.00 | - | |
| Frederick M. Hudson | Derivative | Stock Option (Right to Buy) | 6,124 | $0.00 | - | |
 John H. Tucker - Officer | Other | Common Stock | 122,345 | - footnote F1,F2 | - | |
| John H. Tucker - Officer | Derivative | Common Stock | 318,502 | - footnote F3 | - | |
| John H. Tucker - Officer | Derivative | Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| John H. Tucker - Officer | Derivative | Stock Option (Right to Buy) | 84,500 | $0.00 | - | |
| John H. Tucker - Officer | Derivative | Stock Option (Right to Buy) | 249,000 | $0.00 | - | |
| John H. Tucker - Officer | Derivative | Stock Option (Right to Buy) | 496,674 | $0.00 | - | |
| ||||||
 Klaus R. Dr Veitinger | Derivative | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Klaus R. Dr Veitinger | Derivative | Stock Option (Right to Buy) | 19,750 | $0.00 | - | |
| Klaus R. Dr Veitinger | Derivative | Stock Option (Right to Buy) | 16,300 | $0.00 | - | |
| Klaus R. Dr Veitinger | Derivative | Stock Option (Right to Buy) | 6,124 | $0.00 | - | |
 Leonard D. Schaeffer | Other | Common Stock | 68,796 | - footnote F1,F2 | - | |
| Leonard D. Schaeffer | Other | Common Stock | 43,104 | - footnote F1,F2 | - | |
| Leonard D. Schaeffer | Derivative | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Leonard D. Schaeffer | Derivative | Stock Option (Right to Buy) | 19,750 | $0.00 | - | |
| Leonard D. Schaeffer | Derivative | Stock Option (Right to Buy) | 16,300 | $0.00 | - | |
| ||||||
| Klaus R. Dr Veitinger | Grant or award | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
| Leonard D. Schaeffer | Grant or award | Stock Option (Right to Buy) | 30,000 | $0.00 | - | |
SCPH insider trading FAQ
What is the latest insider trade for SCPH?
scPharmaceuticals Inc. (SCPH) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-10-07. The full record for SCPH runs to 12 Form 4 filings, the earliest from 2025-06-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SCPH stock?
No insider purchases of SCPH were filed in the last 90 days.
How many insiders are selling SCPH stock?
No insider sales of SCPH were filed in the last 90 days.
Where can I see SCPH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SCPH Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - William Tober Abraham view on EDGAR
- - Minnie Baylor-Henry view on EDGAR
- - Rachael Nokes view on EDGAR
- - Mette Kirstine Agger view on EDGAR
- - Sara Bonstein view on EDGAR
- - Jack A. Khattar view on EDGAR
- - Frederick M. Hudson view on EDGAR
- - John H. Tucker view on EDGAR
- - Klaus R. Dr Veitinger view on EDGAR
- - Leonard D. Schaeffer view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where SCPH's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SCPH with a 7-day demo
- SCPH on your watchlist
- Every SCPH Form 4 filing on record
- Up to 3 months of SCPH price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
